Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 2/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19201526 | 1.00 | TDP1 (0.48) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL8943002 | 1.00 | TDP1 (0.48) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL2128168 | 1.00 | TDP1 (0.48) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL6564377 | 1.00 | TDP1 (0.48) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL129425 | 0.96 | TDP1 (0.50) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL44781 | 0.96 | TDP1 (0.50) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL130804 | 0.96 | TDP1 (0.50) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL33424 | 0.96 | TDP1 (0.50) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL12816270 | 0.96 | TDP1 (0.50) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 | |
| SCHEMBL130805 | 0.96 | TDP1 (0.50) | TDP1PABPC1APOBEC3AAPOBEC3GCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034332-A1 | POLYESTER POLYCARBONATE POLYOL | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-01-30 | — | — | US | disclosed |
| WO-2023080134-A1 | POLYESTER POLYCARBONATE POLYOL | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| WO-2017109855-A1 | THIAZOLE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL GERMICIDE INCLUDING SAME | 株式会社エス・ディー・エス バイオテック | 2017-06-29 | — | — | WO | disclosed |
| EP-1240140-B1 | METHOD FOR THE PRODUCTION OF N-ALKENYL AMIDES | BASF AG (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-6673920-B2 | REACTING AMIDES WITH ACETYLENES IN THE LIQUID PHASE IN THE PRESENCE OF BASIC ALKALI METAL COMPOUNDS AND OF A COCATALYST, WHICH COMPRISES USING AS THE COCATALYST DIOLS TO PREPARE N-ALKENYL-AMIDE | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-06 | — | — | US | disclosed |
| US-20030036659-A1 | Method for the production of n-alkenyl amides | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036659-A1 | Method for the production of n-alkenyl amides | NAT1, SAT1, AGPAT2 | TDP1 3329/4885PABPC1 3540/4885APOBEC3A 2173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.